AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9833299
Drug: Intermittent ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent ondansetron (24 mg i.v. q 12 h/day)
Trial: 9833299
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion ondansetron (8 mg i.v. loading dose followed by a continuous infusion of 2 mg/h per day)
Trial: 17052816
Drug: 23-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae type 1 capsular polysaccharide antigen
DrugBank: Streptococcus pneumoniae type 1 capsular polysaccharide antigen (DB10319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent pneumococcal vaccine
Trial: 30415646
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal daily schedules writing)
Trial: 28758542
Drug: Standard Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Group (SG) - weekly two-hour exercise session for six weeks
Trial: 23055001
Drug: Methylphenidate treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate treatment in a 2-week, double-blind, placebo-controlled trial
Trial: 16838235
Drug: 5% acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% acyclovir cream (topical iontophoretic application)
Trial: 9106687
Drug: Preoperative hyperthermia
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative hyperthermia combined with chemotherapy and irradiation (HCR therapy) followed by surgery
Trial: 9106687
Drug: Preoperative hyperthermia
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative hyperthermia combined with chemotherapy and irradiation (HCR therapy) plus surgery
Trial: 8195847
Drug: Brodimoprim (BDP)
RxNorm normalized name: brodimoprim
DrugBank: Brodimoprim (DB13795)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brodimoprim (BDP) 400 mg loading dose followed by 200 mg once a day
Trial: 8195847
Drug: Amoxicillin (AMX)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (AMX) 750 mg t.i.d
Trial: 27075370
Drug: Rapid palatal
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid palatal expansion with a hyrax-type expander, activated twice a day for 15 days to obtain 7.5 mm of palatal expansion, left in situ for six months.
Trial: 27075370
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, only observation).
Trial: 20456813
Drug: Healthy diet+PS
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy diet+PS (2 g/d of PS)
Trial: 20456813
Drug: Free diet+PS
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free diet+PS (2 g/d of PS)
Trial: 10599658
Drug: 1 500-mg
RxNorm normalized name: levocarnitine 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 500-mg tablet of levofloxacin (group 1, 22 patients)
Trial: 10599658
Drug: 2 500-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 500-mg tablets of levofloxacin (group 2, 23 patients)
Trial: 7794081
Drug: Preoperative chemoradiation
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemoradiation therapy (Fluorouracil, cisplatin, and 4500 cGy over 5 weeks)
Trial: 7794081
Drug: Preoperative chemoradiation
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemoradiation therapy
Trial: 9124166
Drug: Sotalol 160
RxNorm normalized name: sotalol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 160 mg twice daily
Trial: 11471639
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of ibuprofen
Trial: 17524266
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) 10 mg once daily for 12 weeks
Trial: 8205603
Drug: TCV-116 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCV-116 (2.5 mg and greater)
Trial: 8205603
Drug: TCV-116 (repeated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCV-116 (repeated administration, once-daily for 8 days)
Trial: 8205603
Drug: TCV-116 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCV-116 (single doses)
Trial: 8205603
Drug: TCV-116 (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCV-116 (first 24 hours post-administration)
Trial: 8205603
Drug: TCV-116 (repeated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCV-116 (repeated administration)
Trial: 30561840
Drug: Baclofen (GABA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (GABA B receptor agonist)
Trial: 24933773
Drug: 17% EDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17% EDTA (used at the end of root canal preparation)
Trial: 17488800
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg daily for 6 weeks
Trial: 17488800
Drug: Hydrochlorothiazide 12.5
RxNorm normalized name: hydrochlorothiazide 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 12.5 mg daily for 6 weeks
Trial: 16054412
Drug: Low normal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low normal protein content (LNP) diet (10 E%; 0.9 g protein/kg body weight)
Trial: 16054412
Drug: High normal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High normal protein content (HNP) diet (20 E%; 1.8 g protein/kg body weight)
Trial: 12398257
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg during week 1, 100 mg during week 2, 150 mg during weeks 3, 4, and 5)
Trial: 261957
Drug: Metoprolol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (150 mg/die)
Trial: 31424568
Drug: Any adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any adjuvant treatment
Trial: 28341243
Drug: Non-preserved gel
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-preserved gel solution of carboxymethylcellulose
Trial: 19500003
Drug: Powdered Nigella
RxNorm normalized name: Nigella sativa seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered Nigella sativa (Kalonji) seed in capsules
Trial: 10051763
Drug: Buprenorphine (partial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (partial opioid agonist)
Trial: 3731680
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 mg)
Trial: 7747291
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg every 12 h for 3 days
Trial: 7747291
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg every 6 h for 3 days
Trial: 7747291
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid 500 mg every 6 h for 3 days
Trial: 7747291
Drug: Pivmecillinam 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pivmecillinam 500 mg every 6 h for 3 days
Trial: 2106804
Drug: Continuous ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ranitidine infusions
Trial: 2106804
Drug: Continuous ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ranitidine infusions with enteral nutrition via nasogastric tube
Trial: 3221935
Drug: Levamisole immunotherapy
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole immunotherapy
Trial: 27469537
Drug: 1 hand
RxNorm normalized name: Upside Down Set Vol 1 Handcare KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 hand therapy visit at 10-14 days postoperatively
Trial: 24614837
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) 100 mg/kg/day
Trial: 19818450
Drug: 0.45% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% saline solution at 100% maintenance rate
Trial: 19818450
Drug: 0.45% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% saline solution at 50% maintenance rate
Trial: 19818450
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline solution at 100% maintenance rate
Trial: 19818450
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline solution at 50% maintenance rate
Trial: 19818450
Drug: Fluid administration
RxNorm normalized name: Fluid Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid administration rate
Trial: 15694213
Drug: IMPACT intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IMPACT intervention (multidisciplinary depression treatment program with care manager support)
Trial: 12001042
Drug: Continuation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation with protease inhibitor plus nucleoside-analogue combination regimens (n=79)
Trial: 7768298
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (200 micrograms) administered twice daily for 2 weeks
Trial: 2180106
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 40 mg per day for 14 days
Trial: 2180106
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate 500 micrograms thrice daily for 14 days
Trial: 7256808
Drug: Combined radiotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined radiotherapy schemes (external and intracavitary radiations given alternately with unequal doses)
Trial: 7256808
Drug: Modified approximate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified approximate CRE and nominal dose methods
Trial: 16945514
Drug: 5 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL/kg of pentastarch (group A)
Trial: 16945514
Drug: 10 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL/kg of pentastarch (group B)
Trial: 10987233
Drug: Postmastectomy radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmastectomy radiotherapy and systemic treatment
Trial: 22431703
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment alone
Trial: 8800358
Drug: 4% CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% CO2 inhalation during exhaustive maximal two‐legged cycling
Trial: 8800358
Drug: No CO2
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No CO2 inhalation during exhaustive maximal two‐legged cycling
Trial: 6336641
Drug: Bicozamycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicozamycin (500 mg orally four times daily for 3 days)
Trial: 29265040
Drug: Pharmaceutical Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical Care Group (PC)
Trial: 24400655
Drug: Alogliptin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin plus Metformin (A+M) 12.5/500 mg BID
Trial: 24400655
Drug: Alogliptin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin plus Metformin (A+M) 12.5/1000 mg BID
Trial: 24400655
Drug: Alogliptin (A)
DrugBank: Alogliptin (DB06203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alogliptin (A) 12.5 mg BID
Trial: 24400655
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M) 500 mg BID
Trial: 24400655
Drug: Metformin (M)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (M) 1000 mg BID
Trial: 24400655
Drug: Alogliptin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin plus Metformin (A+M)
Trial: 24400655
Drug: Alogliptin (A)
DrugBank: Alogliptin (DB06203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alogliptin (A) and Metformin (M) monotherapies
Trial: 22932329
Drug: Bipolar coagulation
RxNorm normalized name: Coagulation factor XIa
DrugBank: Coagulation factor XIa (DB15420)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bipolar coagulation therapy
Trial: 11403192
Drug: 1% cidofovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% cidofovir cream
Trial: 3386087
Drug: Cisapride 15
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisapride 15 mg/day
Trial: 3386087
Drug: Cisapride 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 7.5 mg/day
Trial: 19120074
Drug: Antiviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral therapy (Ganciclovir and valganciclovir) for 3 weeks
Trial: 19120074
Drug: Antiviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiviral therapy (Ganciclovir and valganciclovir)
Trial: 17805109
Drug: Intraoperative topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative topical Sensorcaine
Trial: 14754739
Drug: EndoPearl adjunct
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EndoPearl adjunct to bioabsorbable interference screw fixation
Trial: 10999089
Drug: benidipine 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benidipine 4 mg/day
Trial: 10999089
Drug: benidipine 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benidipine 8 mg/day
Trial: 10999089
Drug: benidipine 4-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benidipine 4-8 mg/day
Trial: 7007454
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg folate tablets (Group B)
Trial: 7007454
Drug: Placebo mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouthwash and tablets (Group A)
Trial: 7007454
Drug: Placebo mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouthwash and 5 mg folate tablets (Group B)
Trial: 26053853
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/HCTZ 12.5 mg (NLSD)
Trial: 26053853
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg/HCTZ 12.5 mg (NLSD)
Trial: 26053853
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg (NLSD)
Trial: 3094439
Drug: Ciprofloxacin 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 0.25 g single dose
Trial: 3094439
Drug: Ampicillin 3.5
RxNorm normalized name: AMPICILLIN 3.5/PROBENECID 1GM SUSP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 3.5 g plus probenecid 1.0 g
Trial: 31223624
Drug: General public
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General public awareness of prescription drugs
Trial: 31223624
Drug: General public
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General public awareness of antibiotic use
Trial: 31223624
Drug: General public
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General public awareness of antibiotic resistance (AR)
Trial: 31223624
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of prescription medicine by gender
Trial: 31223624
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of antibiotic resistance by occupation
Trial: 31223624
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of prescription medicine by ethnicity
Trial: 28750585
Drug: 0.3 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g/kg β‐OHB ketone salts
Trial: 19151046
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (100-4000 microg)
Trial: 11125190
Drug: Tunnel preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tunnel preparation
Trial: 20188783
Drug: Class II
RxNorm normalized name: HLA class II antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class II cavity preparation
Trial: 9329638
Drug: Comet assay
RxNorm normalized name: Cometriq
DrugBank: Cabozantinib (DB08875)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Comet assay (single‐cell gel electrophoresis) for measuring DNA strand breaks
Trial: 8356846
Drug: Trivalent CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent CR vaccine (A H1N1 (CR‐125), A H3N2 (CR‐149), and B (CRB‐117))
Trial: 8356846
Drug: Bivalent CR
RxNorm normalized name: L1 protein, human papillomavirus type 16 vaccine
DrugBank: Human papillomavirus type 16 L1 capsid protein antigen (DB10301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent CR vaccine (CR‐125 and CR‐149)
Trial: 8356846
Drug: Inactivated split
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated split vaccine
Trial: 3437376
Drug: Bromocriptine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (5 mg orally administered)
Trial: 1091686
Drug: Diphenylhydantoin (DPH)
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diphenylhydantoin (DPH) 100 mg twice daily
Trial: 15553010
Drug: Protocol A
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A (fixed injection rate of 2.0 mL/sec with a 70 sec delay)
Trial: 9398090
Drug: No antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiarrhythmic treatment (Control)
Trial: 8417877
Drug: Theophylline (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (300 mg sustained-release, four doses at 12-hour intervals)
Trial: 8046314
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg b.i.d.)
Trial: 3091717
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) (1 g t.i.d.)
Trial: 20356395
Drug: Yoga classes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga classes (12 weekly sessions)
Trial: 31667747
Drug: Physical Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Therapy (PT) sessions (1-on-1)
Trial: 29763832
Drug: Regular pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular pain assessment using the Doloplus-2 scale twice a week for 12 weeks
Trial: 19213349
Drug: Sanjie Zhentong
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sanjie Zhentong Capsule (SJC)
Trial: 16641447
Drug: Cefditoren-pivoxil 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefditoren-pivoxil 200 mg twice daily for 5 days
Trial: 16641447
Drug: Cefuroxime-axetil 250
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime-axetil 250 mg twice daily for 10 days
Trial: 11959766
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml 0.5% bupivacaine
Trial: 2174652
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml 0.9% saline
Trial: 9585794
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 to 40 mg/day) + Moclobemide (up to 600 mg/day)
Trial: 9585794
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 to 40 mg/day)
Trial: 85322
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (CHOP + bleomycin or COP + bleomycin)
Trial: 30355790
Drug: Subcutaneous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous treatment with bemiparin 3500 IU/0.2 mL/day
Trial: 24702571
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine plus dexmedetomidine administration (Phase M+D)
Trial: 24702571
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine administration (Phase M)
Trial: 2586565
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical treatment
Trial: 17666461
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intensive medical treatment and self-management course
Trial: 7608322
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration (2 mg)